Your browser doesn't support javascript.
loading
Identification of Z-Tyr-Ala-CHN2, a Cathepsin L Inhibitor with Broad-Spectrum Cell-Specific Activity against Coronaviruses, including SARS-CoV-2.
Doijen, Jordi; Temmerman, Koen; Van den Eynde, Christel; Diels, Annick; Van den Broeck, Nick; Van Gool, Michiel; Heo, Inha; Jaensch, Steffen; Zwaagstra, Marleen; Diosa Toro, Mayra; Chiu, Winston; De Jonghe, Steven; Leyssen, Pieter; Bojkova, Denisa; Ciesek, Sandra; Cinatl, Jindrich; Verschueren, Lore; Buyck, Christophe; Van Kuppeveld, Frank; Neyts, Johan; Van Loock, Marnix; Van Damme, Ellen.
Afiliación
  • Doijen J; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Temmerman K; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Van den Eynde C; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Diels A; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Van den Broeck N; Charles River Laboratories, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Van Gool M; Janssen Cilag S.A., C/Jarama 75A, 45007 Toledo, Spain.
  • Heo I; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Jaensch S; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Zwaagstra M; Faculty of Veterinary Medicine, Yalelaan 1, Virology Division, Department of Biomolecular Health Sciences, Infectious Diseases and Immunology, Utrecht University, 3584 Utrecht, The Netherlands.
  • Diosa Toro M; Faculty of Veterinary Medicine, Yalelaan 1, Virology Division, Department of Biomolecular Health Sciences, Infectious Diseases and Immunology, Utrecht University, 3584 Utrecht, The Netherlands.
  • Chiu W; Laboratory of Virology and Chemotherapy, Herestraat 49, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
  • De Jonghe S; Laboratory of Virology and Chemotherapy, Herestraat 49, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
  • Leyssen P; Laboratory of Virology and Chemotherapy, Herestraat 49, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
  • Bojkova D; Institute for Medical Virology, University Hospital, Paul-Ehrlich-Str. 40, Frankfurt University, 60596 Frankfurt am Main, Germany.
  • Ciesek S; Institute for Medical Virology, University Hospital, Paul-Ehrlich-Str. 40, Frankfurt University, 60596 Frankfurt am Main, Germany.
  • Cinatl J; Institute for Medical Virology, University Hospital, Paul-Ehrlich-Str. 40, Frankfurt University, 60596 Frankfurt am Main, Germany.
  • Verschueren L; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Buyck C; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Van Kuppeveld F; Faculty of Veterinary Medicine, Yalelaan 1, Virology Division, Department of Biomolecular Health Sciences, Infectious Diseases and Immunology, Utrecht University, 3584 Utrecht, The Netherlands.
  • Neyts J; Laboratory of Virology and Chemotherapy, Herestraat 49, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
  • Van Loock M; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Van Damme E; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Microorganisms ; 11(3)2023 Mar 10.
Article en En | MEDLINE | ID: mdl-36985290

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Microorganisms Año: 2023 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Microorganisms Año: 2023 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza